Department of Cell Biology and Human Anatomy, Institute for Pediatric Regenerative Medicine, School of Medicine, University of California, Davis, 2425 Stockton Boulevard, Sacramento, CA 95817, USA.
Trends Biotechnol. 2010 Apr;28(4):214-23. doi: 10.1016/j.tibtech.2010.01.002. Epub 2010 Feb 9.
Cell reprogramming, in which a differentiated cell is made to switch its fate, is an emerging field with revolutionary prospects in biotechnology and medicine. The recent discovery of induced pluripotency by means of in vitro reprogramming has made way for unprecedented approaches for regenerative medicine, understanding human disease and drug discovery. Moreover, recent studies on regeneration and repair by direct lineage reprogramming in vivo offer an attractive novel alternative to cell therapy. Although we continue to push the limits of current knowledge in the field of cell reprogramming, the mechanistic elements that underlie these processes remain largely elusive. This article reviews landmark developments in cell reprogramming, current knowledge, and technological developments now on the horizon with significant promise for biomedical applications.
细胞重编程是指将分化细胞的命运进行转换的新兴领域,在生物技术和医学领域具有革命性的前景。最近通过体外重编程发现的诱导多能性为再生医学、人类疾病的理解和药物发现开辟了前所未有的方法。此外,最近关于体内直接谱系重编程的再生和修复的研究为细胞治疗提供了一种有吸引力的新选择。尽管我们继续在细胞重编程领域推动现有知识的极限,但这些过程背后的机制元素在很大程度上仍难以捉摸。本文综述了细胞重编程的标志性发展、当前的知识以及即将出现的技术发展,这些发展为生物医学应用带来了巨大的希望。